Who we are

ECELLFRANCE is the French Research Infrastructure for mesenchymal stem cell (MSC)-based therapies.





Since its creation in 2012, it has been involved in over 20 national and European research & innovation programs in cell-based therapy.

It brings together :

  • State-of-the-art Advanced Therapy Medicinal Products (ATMP) production platforms
  • Immunomonitoring and quality control platforms
  • Research teams with expertise on translational research in cell therapy
  • Clinical research teams to cover phase I and II clinical studies

In the fields of :

  • Osteoarticular diseases
  • Autoimmune diseases
  • Cutaneous conditions
  • Ischemia
  • Stroke and neurological disorders


ECELLFRANCE is open to academics and industrials requesting support for their pre-clinical and/or clinical programs in the field of cell-based therapies. The infrastructure provides services covering the entire MSC-based production and development pipeline including:

- Project validation - Production of ATMP - Immunomonitoring
- Preclinical studies

- Safety and potency tests


- Regulatory support

- Phase I and II clinical trials


Application form

Service requests can be submitted by filling the application form.






Brochure available here.